Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.

Sylvester Garrett, T Jenkinson, L G Kennedy et al. · PubMed · 1994 · 3.2K citations

A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

A Cãlin, H Whitelock, L G Kennedy et al. · PubMed · 1994 · 1.8K citations

ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis

Désirée van der Heijde, E. Lie, Tore K Kvien et al. · Annals of the Rheumatic Diseases · 2008 · 619 citations

Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis

Jennifer J. Anderson, Gabriel Baron, Désirée van der Heijde et al. · Arthritis & Rheumatism · 2001 · 608 citations · Full text

Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double‐blind, placebo‐controlled, phase III trial

Robert D. Inman, John C. Davis, Désirée van der Heijde et al. · Arthritis & Rheumatism · 2008 · 590 citations